SCYX NASDAQ
SCYNEXIS, Inc.
1W: +16.6%
1M: -1.9%
3M: +8.2%
YTD: +701.9%
1Y: +533.4%
3Y: +142.7%
5Y: -8.2%
$5.12
-0.25 (-4.66%)
Weekly Expected Move ±11.7%
$4
$5
$5
$6
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$32.2M
52W Range3.53-9.12
Volume132,389
Avg Volume241,166
Beta1.11
Dividend—
Analyst Ratings
Company Info
CEODavid Angulo
Employees18
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2014-05-02
Websitescynexis.com
1 Evertrust Plaza
Jersey City, NJ 07302-6548
US
Jersey City, NJ 07302-6548
US
201 884 5485
About SCYNEXIS, Inc.
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
Latest News
SCYNEXIS appoints Sanjay Subramanian as CFO
SCYNEXIS (NASDAQ:SCYX) Stock Price Passes Above Fifty Day Moving Average – Here’s What Happened
SCYNEXIS (NASDAQ:SCYX) Shares Pass Below 200 Day Moving Average – Should You Sell?
SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update
SCYNEXIS (NASDAQ:SCYX) Shares Cross Below 200 Day Moving Average – Time to Sell?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Burke Steven Keith | A-Award | 5,750 | — | 2026-09-18 |
| Burke Steven Keith | A-Award | 5,750 | $4.46 | 2026-09-18 |
| Burke Steven Keith | 0 | — | 2026-09-18 | |
| Subramanian Sanjay | A-Award | 100,000 | $4.91 | 2026-09-09 |
| Subramanian Sanjay | 0 | — | 2026-09-09 |